The World Health Organization says it has cleared the Pfizer-BioNTech coronavirus vaccine for emergency use, which means poorer nations could quickly get entry to the shot already accessible in Europe and North America.
Every nation that has a drug regulatory company should subject its personal approval for any COVID-19 vaccine, however nations with weak techniques normally depend on WHO to vet the photographs.
The world physique mentioned late Thursday that the choice to subject its first emergency use validation for a COVID-19 vaccine “opens the door for countries to expedite their own regulatory approval processes to import and administer the vaccine.”
The UN well being company mentioned its evaluation discovered the Pfizer-BioNTech vaccine, which has already acquired clearance within the United States, Britain, the European Union and a dozen different nations, “met the must-have criteria for safety and efficacy set out by WHO.”
The BioNTech-Pfizer vaccine must be saved at ultra-frozen temperatures, an enormous hurdle for creating nations the place the required freezers and dependable electrical energy provide is probably not accessible.
“This requirement makes the vaccine more challenging to deploy in settings where ultra-cold chain equipment may not be available or reliably accessible,” WHO mentioned, including that it was “working to support countries in assessing their delivery plans and preparing for use where possible”.